LEI 549300FI0P3XDOCBXJ78

AbbVie Deutschland GmbH And Co. KG

Group parent: ABBVIE INC.

Awards tracked

11

Value

€260,539

Countries

DE

Download sample CSV

Contract awards & public grants

Germany – Pharmaceutical products – Vereinbarung nach § 130c SGB V für das Arzneimittel Maviret mit der Wirkstoffkombination Glecaprevir/Pib → AbbVie Deutschland GmbH & Co. KG

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen · DE · Tender · 2026-07-07

—

FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE → ABBVIE DEUTSCHLAND GMBH & CO KG

European Commission · DE · Grant · 2026-06-02

—

Advancing Safe and Sustainable by design Practices in Pharmaceutical Manufacturing → ABBVIE DEUTSCHLAND GMBH & CO KG

European Commission · DE · Grant · 2024-12-05

—

Macrocycles for Drug Discovery → ABBVIE DEUTSCHLAND GMBH & CO KG

European Commission · DE · Grant · 2024-07-10

€260,539

GUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRD → ABBVIE DEUTSCHLAND GMBH & CO KG

European Commission · DE · Grant · 2023-05-17

—

Artificial intelligence-based Parkinson’s disease risk assessment and prognosis → ABBVIE DEUTSCHLAND GMBH & CO KG

European Commission · DE · Grant · 2023-04-11

—

Inhibiting Misfolded protein PRopagation in Neurodegenerative Diseases - Sofia ref.: 116060 → ABBVIE DEUTSCHLAND GMBH & CO KG

European Commission · DE · Grant · 2017-04-07

—

Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 → ABBVIE DEUTSCHLAND GMBH & CO KG

European Commission · DE · Grant · 2017-03-10

—

Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030 → ABBVIE DEUTSCHLAND GMBH & CO KG

European Commission · DE · Grant · 2016-12-22

—

Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 → ABBVIE DEUTSCHLAND GMBH & CO KG

European Commission · DE · Grant · 2016-12-16

—

Alzheimers Disease Apolipoprotein Pathology for Treatment Elucidation and Development - Sofia ref.: 115975 → ABBVIE DEUTSCHLAND GMBH & CO KG

European Commission · DE · Grant · 2016-11-09

—

Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.